Aspect Biosystems
Founded 2013 · 145 employees on LinkedIn · 11 known investors
Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues. Its pipeline targets metabolic and endocrine diseases, and it partners with pharma and biotech companies to advance cell therapies to the clinic.
Founders & leadership
Aspect Biosystems was founded in 2013 by Tamer Mohamed, Sam Wadsworth, and Simon Beyer.
Investors · 11
Angel ForumVancouvervia Irene Dorsman · inferred
Civilization Ventures Management, LlcTiburon · $1M – $10M
InBC Investment Corp.British Columbia · $3M – $10M
JDRF T1D FundBoston
Page One VenturesSilicon Valley
Pallasite VenturesVancouver · $100K – $1.5M
Pangaea Ventures Us Inc.Vancouver · $500K – $1.5M
Radical VenturesToronto · $1M – $25M
Relentless Pursuit PartnersVancouver
Rising TidePacifica
Dimension CapitalreportedSan Francisco · $1M – $10M
Competitors · 3
by search overlap
Fortis Life Sciences8 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
PrintBio8 shared keywordsPrintBio is a clinical- and commercial-stage biotechnology company developing 3D-bioprinting and material science technologies to create bioresorbable surgical mesh products, including its DynaFlex and DynaForm Programmable Surgical Mesh lines for soft tissue repair and reinforcement. Working with surgeons, the company also builds living tissue implants for patients in regenerative medicine.
Aspect8 shared keywordsAspect provides workforce management software for contact centers, offering forecasting, scheduling, intraday management, and adherence tracking, plus an AI product (Aspect Intelligence) that anticipates risk and automatically adjusts schedules. It serves large enterprises and call center operations aiming to optimize staffing while maintaining service levels and compliance.
Companies competing with Aspect Biosystems for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Aspect Biosystems do?
- Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues. Its pipeline targets metabolic and endocrine diseases, and it partners with pharma and biotech companies to advance cell therapies to the clinic.
- Who founded Aspect Biosystems?
- Aspect Biosystems was founded by Tamer Mohamed, Sam Wadsworth, Simon Beyer in 2013.
- Who are Aspect Biosystems's investors?
- Aspect Biosystems's investors include Angel Forum, Civilization Ventures Management, Llc, InBC Investment Corp., JDRF T1D Fund, Page One Ventures, Pallasite Ventures, Pangaea Ventures Us Inc., Radical Ventures and 3 more.